Affimed N.V.
AFMD · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.6% | -0.6% | -62.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $10 | $12 | $15 | $19 |
| G&A Expenses | $4 | $4 | $4 | $6 |
| SG&A Expenses | $4 | $4 | $4 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $14 | $16 | $20 | $25 |
| Operating Income | -$14 | -$16 | -$20 | -$21 |
| % Margin | -9,214.8% | -10,099.4% | -12,603.2% | -5,044.8% |
| Other Income/Exp. Net | -$1 | $0 | $0 | $1 |
| Pre-Tax Income | -$15 | -$15 | -$19 | -$20 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15 | -$15 | -$19 | -$20 |
| % Margin | -9,767.1% | -10,033.1% | -12,371% | -4,892.3% |
| EPS | -0.94 | -1.01 | -1.27 | -1.35 |
| % Growth | 6.9% | 20.5% | 5.9% | – |
| EPS Diluted | -0.94 | -1.01 | -1.27 | -1.35 |
| Weighted Avg Shares Out | 16 | 15 | 15 | 15 |
| Weighted Avg Shares Out Dil | 16 | 15 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $2 | $0 |
| EBITDA | -$14 | -$15 | -$17 | -$19 |
| % Margin | -9,320% | -9,546.8% | -10,788.4% | -4,677.2% |